Priapism Shunts & Decompression

This page is the operative atlas companion for refractory ischemic priapism. It covers distal corporoglanular shunts, tunneling maneuvers, penoscrotal decompression (PSD), historical proximal shunts, and the transition point to early penile prosthesis. For diagnosis, corporal blood gas interpretation, phenylephrine dosing, sickle-cell considerations, and non-ischemic priapism, use the emergency-condition page: Priapism.

The organizing principle is simple: ischemic priapism is a corporal compartment syndrome. Medical therapy evacuates and pharmacologically contracts the corpora; shunt surgery creates outflow when aspiration / irrigation / phenylephrine fails. Modern practice strongly favors distal corporoglanular shunts with tunneling and newer glans-sparing decompression strategies. Proximal shunts are mostly historical because they add morbidity without clearly improving resolution.^[1][2][3]

Shunt routes for ischemic priapism, drawn on one organ (proximal crus at left → glans at right). Distal corporoglanular shunts open a window at the corpus cavernosum–glans junction — compared by size in the inset (Winter needle core → Ebbehoj blade stab → T-shunt cruciate → Al-Ghorab excised disc) — and the Burnett snake maneuver then passes a Hegar dilator down the corporal body to clear the proximal clot column. The proximal Quackels (cavernosum → spongiosum) and Grayhack (saphenous-vein graft) shunts — and the deep-dorsal-vein Barry variant — are largely abandoned, adding morbidity without improving resolution. (Original WARWIKI schematic)

---

Algorithmic Placement

Clinical setting	Preferred operative move	Avoid
Persistent ischemic priapism after aspiration / irrigation / phenylephrine	Distal corporoglanular shunt, usually T-shunt or Al-Ghorab depending on setting and surgeon experience	Repeating ineffective bedside aspiration for hours while ischemic time accumulates
Prolonged priapism with thick clot or failed simple distal shunt	Add corporal tunneling (Burnett snake maneuver) or proceed to PSD	Tiny needle shunts that cannot clear organized proximal clot
Failed distal shunt / failed tunneling	PSD or early penile prosthesis, based on duration, corporal viability, patient goals, and local expertise	Proximal shunt as reflex salvage
Very late presentation, nonviable corpora, or failed decompression	Acute malleable penile prosthesis or planned early prosthesis strategy	Delayed implantation without counseling about fibrosis and length loss

For ischemic priapism lasting more than 36 hours, conservative non-surgical management has high retreatment burden. A 2026 consecutive cohort found readmission / reintervention in 66.7% of non-surgically managed patients vs 10.4% after surgical management.^[4]

---

Distal Corporoglanular Shunts

Distal shunts create a communication between the distal corpus cavernosum and the glans / corpus spongiosum. They are first-line surgical procedures because they are fast, anatomically accessible, and can often be performed under local anesthesia with dorsal penile nerve block plus ring block.^[1][5]

Winter Shunt

Feature	Detail
Mechanism	Percutaneous needle core through the glans into the distal corpus cavernosum, removing a core of tunica albuginea to create a small corporo-spongiosal communication
Instrument	Tru-Cut or large-bore core biopsy needle
Shunt window	Small (circular core)
Strength	Simplest bedside shunt under local anaesthesia; minimal equipment
Weakness	Small opening; prone to closure; highest failure rate among distal shunts — Nixon series: 92% of reoperated patients had initially undergone a Winter shunt[3]
Best use	Early refractory ischemic priapism (< 24 h) when a simple distal decompression is reasonable

Winter is the least invasive distal shunt but also the easiest to occlude.^[1][5] Multiple passes may be made bilaterally to increase the shunt size. The small window may be insufficient for adequate drainage in prolonged priapism with thick, gelatinous, or organised clot — the Burnett "Snake" maneuver cannot be combined with the Winter shunt because the window is too small to accept a Hegar dilator.^[1][8]

Efficacy. Nixon retrospective: ~ 50% of patients required reoperation for failed detumescence after cavernosa-to-spongiosum shunts, and 92% of those who failed had initially undergone a Winter shunt — Al-Ghorab and Quackels rarely required reoperation in the same series.^[3] Across the broader literature, distal-shunt resolution rates range 18.7–100% and potency rates 20–100% (heterogeneous by priapism duration).^[6]

Ebbehoj Shunt

Feature	Detail
Mechanism	Percutaneous scalpel stab through the glans into the distal corpus cavernosum; blade rotated or withdrawn to create a linear incision (rather than a core biopsy)
Instrument	No. 11 scalpel blade
Shunt window	Moderate (linear incision) — slightly larger than Winter
Strength	Slightly larger opening than Winter while remaining simple; no tissue removal
Weakness	Still a small distal opening; urethral injury risk if directed too ventrally; not easily combined with the Snake maneuver (window too small for dilator passage)
Best use	Early refractory cases where a percutaneous blade shunt is preferred over needle coring

First described by Ebbehoj 1974 as a modification of the Winter shunt that uses a scalpel blade rather than a biopsy needle to create the corporo-spongiosal fistula.^[1] Conceptually similar to Winter but creates a larger tunical defect; the blade should be directed into the distal corporal tip and kept away from the ventral urethra.^[1][5]

Efficacy. Most outcome studies group the Ebbehoj with other distal shunts — individual efficacy data are limited. Generally considered to have intermediate efficacy between the Winter and Al-Ghorab shunts given its moderately larger window.^[3][7] A persistent glans-cavernosum fistula can itself cause ED from venous leak; fistula closure has been reported to restore erections in select cases.^[18]

T-Shunt (Lue)

Feature	Detail
Mechanism	Scalpel inserted percutaneously through the lateral glans (2 o'clock or 10 o'clock, avoiding the urethra ventrally and the dorsal NVB), advanced into the distal corpus cavernosum; rotated 90° to create a cruciate (T-shaped) opening in the tunica albuginea
Instrument	No. 10 scalpel blade
Shunt window	Large (cruciate) — significantly larger than Winter or Ebbehoj
Strength	Wider, more durable distal opening; compatible with the Burnett Snake maneuver (7–8 mm Hegar dilator); allows simultaneous corporal biopsy for smooth-muscle viability assessment; bedside under local anaesthesia
Weakness	More tissue disruption; urethral injury risk if trajectory is wrong (mitigated by lateral glans entry + Foley catheter); urethrocutaneous-fistula risk with Snake maneuver[10]
Best use	Preferred percutaneous distal shunt for many refractory cases, especially when tunneling will be needed

The T-shunt was designed to create a larger and more durable distal corporal exit than Winter or Ebbehoj. Brant / Lue 2009 original series (n = 13) — cavernous blood flow restored in 12/13 (92%); all but 2 recovered erectile function; 6 of these patients had previously undergone unsuccessful distal or proximal shunt procedures before the T-shunt.^[6]

Step-by-step (Brant–Lue):^[6]

1. Local anaesthesia (dorsal penile-nerve block + ring block) suitable for bedside / ED use.
2. Foley catheter placed to identify the urethra and prevent urethral injury.
3. No. 10 blade inserted through lateral glans at 2 o'clock or 10 o'clock, advanced into distal corpus cavernosum, penetrating the tunica albuginea.
4. Blade rotated 90° within the corpus to create the cruciate opening.
5. Dark deoxygenated blood expressed; manual compression facilitates drainage.
6. Performed bilaterally.
7. Snake maneuver (now standard) — 7–8 mm Hegar dilator passed retrograde through the T-shunt window to tunnel the full length of the corpus to the crus, mechanically disrupting clotted blood.^[6][8]
8. Optional corporal biopsy — necrotic smooth muscle on biopsy is highly predictive of severe ED and shunt failure and may guide early prosthesis decisions.^[7]
9. Closure with absorbable sutures; compressive dressing.

Efficacy:

• Brant / Lue 2009 — 92% blood-flow restoration in n = 13.^[6]
• Zacharakis 2014 T-shunt + Snake (n = 45) — 100% resolution when duration < 48 h; all patients > 48 h had necrotic cavernous smooth muscle on biopsy and severe ED requiring prosthesis.^[7]
• Ortaç 2019 T-shunt ± tunneling (n = 25) — 100% rapid resolution but 84.2% postoperative ED (median duration 58 h); only 15.8% achieved unaided intercourse, 31.5% required PDE5i, 47.4% had severe ED.^[19]
• Unal / Burnett 2024 Snake-vs-no-Snake (n = 82) — 92.3% resolution with Snake vs 53.6% without (p < 0.05); recurrence 4.2% vs 26.6%.^[8]

Outcomes by priapism duration (T-shunt ± Snake):

Duration	Resolution	Erectile function	Smooth-muscle biopsy
< 24 h	~ 100%	ED ~ 50%, often mild–moderate; PDE5i-responsive	Viable
24–48 h	~ 60–75%	Moderate–severe ED common	Variable viability
> 48 h	~ 30%	Severe ED in 100%; all require prosthesis	Necrotic smooth muscle in 100%

Anchors: Brant–Lue^[6], Zacharakis^[7].

T-shunt may make proximal shunts obsolete — Brant and Lue suggested the T-shunt with tunneling could eliminate the need for proximal shunt procedures.^[6]

Al-Ghorab Shunt

First described by Al-Ghorab in 1973. Among all distal shunts, the Al-Ghorab produces the largest tunical window because the tunica albuginea is excised under direct vision rather than punctured or incised — making it both the most reliably patent distal shunt and the original platform on which Burnett later developed the Snake maneuver.^[5][8][9]

Feature	Detail
Approach	Open (not percutaneous)
Instrument	Scalpel + scissors / sharp dissection — excises a disc of tunica under direct vision
Shunt window	Largest (excised ~ 5 × 5 mm disc of distal tunica)
Visualization	Direct — glans tissue dissected to expose distal tunical tips
Snake compatible	Yes — originally described here
Anesthesia	Local (dorsal-nerve + ring block), regional, or general
Reoperation rate	Lowest among distal shunts (Nixon series)
Best use	Failed percutaneous shunt, prolonged clot burden, or primary distal procedure when open access is preferred

Step-by-step (Al-Ghorab):^[5][9]

1. Anaesthesia — local (dorsal-nerve + ring block), regional, or general.
2. Transverse or dorsal glans incision (circumcoronal or dorsal-glans approach) exposing the distal corpora cavernosa.
3. Dissect glans tissue to expose the distal tips of the tunica albuginea bilaterally.
4. Excise a disc / cone of tunica albuginea (~ 5 × 5 mm) from each corporal tip under direct vision.
5. Express dark deoxygenated blood; manual shaft compression facilitates drainage.
6. Snake maneuver (now standard) — 7–8 mm Hegar dilator passed retrograde through the excised window to the crus, bilaterally.^[8][9]
7. Blunt cavernosotomy salvage (Shiraishi–Matsuyama) — for very prolonged (5–7 d) priapism refractory to T-shunt/Snake, Pean forceps may be used through the Al-Ghorab window to bluntly excise necrotic/fibrotic cavernosal tissue, enlarging the drainage route.^[20]
8. Optional corporal biopsy — necrotic smooth muscle predicts severe ED and may justify early prosthesis.^[7]
9. Close glans incision with absorbable sutures; compressive dressing.

Efficacy:

• Nixon 2003 (n = 28) — across cavernosa-to-spongiosum shunts ~ 50% required reoperation; 92% of failures had initially undergone a Winter shunt, while reoperation after Al-Ghorab or Quackels was uncommon. ~ 90% had ED at follow-up (primarily duration-driven).^[3]
• Burnett / Pierorazio 2009 (original Snake-with-Al-Ghorab, n = 3) — 2-, 5-, and 6-day priapism refractory to all prior management; 3/3 resolved.^[9]
• Segal / Burnett 2013 (long-term, n = 10) — mean duration 75 h (24–288 h); 6/10 had failed prior surgery; 80% resolved with no recurrence; 2 failures required IPP; 2/6 with preserved preop EF achieved partial postop EF.^[8]
• Shiraishi / Matsuyama 2013 salvage (n = 2, 5- and 7-day priapism refractory to T-shunt/Snake) — Al-Ghorab + blunt cavernosotomy with Pean forceps achieved immediate resolution in both; pathology confirmed fibrotic / necrotic corporal tissue; one patient achieved partial erection on sildenafil.^[20]
• Unal / Burnett 2024 distal shunt ± Snake (n = 82) — 92.3% resolution with Snake vs 53.6% without (p < 0.001); recurrence 4.2% vs 26.6%.^[10]

Distal-shunt comparison:

Feature	Winter	Ebbehoj	T-Shunt	Al-Ghorab
Approach	Percutaneous	Percutaneous	Percutaneous	Open
Instrument	Tru-Cut needle	No. 11 blade	No. 10 blade + 90° rotation	Scalpel + excision under direct vision
Window	Small (core)	Moderate (linear)	Large (cruciate)	Largest (excised disc)
Visualization	Blind	Blind	Blind	Direct
Snake compatible	No	No	Yes	Yes (originally described)
Reoperation rate	Highest (~ 50%)	Intermediate	Lower	Lowest

---

Burnett Snake Maneuver

The Burnett "Snake" maneuver is the most significant technical advance in distal shunt surgery for ischemic priapism — originally described by Burnett and Pierorazio at Johns Hopkins in 2009 as a modification of the Al-Ghorab shunt and later extended to the T-shunt.^[9] It is an adjunct, not a standalone shunt, and addresses the fundamental limitation of a distal window: that opening the corporal tip does not clear the clotted, thrombosed, or sludged blood filling the full length of the corporal body. A 7–8 mm Hegar dilator passed retrograde from window to crus mechanically disrupts that column and restores a patent intracorporal lumen.^[8][9]

Step-by-step (Burnett–Pierorazio):^[9]

1. Prerequisite — adequate distal shunt window. Originally described with the Al-Ghorab; now also performed through the T-shunt. Winter and Ebbehoj windows are too small to accept a Hegar dilator.^[5][9]
2. Anaesthesia per the underlying shunt (local + dorsal-nerve / ring block bedside, or regional/general in the OR).
3. 7–8 mm Hegar cervical dilator (smooth, blunt, graduated metal) inserted retrograde through the distal tunical window into the corporal tip.
4. Dilator advanced proximally through the full length of the corpus cavernosum to the crus at the ischiopubic ramus — the serpentine advancement is the eponymous "snake."
5. Procedure performed bilaterally.
6. Dark deoxygenated, clotted blood expressed; manual shaft compression assists drainage.
7. Confirm patency — dilator should pass smoothly along the full corporal length; postoperative penile Doppler may be used to confirm restored cavernosal flow.
8. Optional corporal biopsy — necrotic smooth muscle predicts severe ED and may guide early-prosthesis decisions.^[7]
9. Close the shunt site (glans incision or stab wounds) with absorbable suture; compressive dressing.

Shunt-compatibility matrix:

Shunt	Snake-compatible?	Rationale
Winter (Tru-Cut needle)	No	Core too small for Hegar dilator
Ebbehoj (No. 11 blade)	No	Linear stab still too narrow
T-Shunt (No. 10 + 90° rotation)	Yes	Cruciate window accommodates dilator
Al-Ghorab (open excision)	Yes — original platform	Largest window; ideal dilator passage

Efficacy across the Snake literature:

Series	n	Setting	Resolution	Erectile function / note
Burnett / Pierorazio 2009 (Al-Ghorab + Snake)	3	2-, 5-, 6-day refractory priapism after failed prior shunting	3/3 (100%)	Meaningful EF recovery assessable in 1[9]
Segal / Burnett 2013 (Al-Ghorab + Snake)	10	Mean duration 75 h (24–288 h); 6/10 prior failed surgery	8/10 (80%) with no recurrence; 2 failures → IPP	2/6 with preop EF achieved partial postop EF[8]
Zacharakis 2014 (T-shunt + Snake)	45	Refractory ischemic priapism	100% if < 48 h	IIEF-5 24 → 7.7 (p < 0.001); all > 48 h had necrotic smooth muscle on biopsy and required prosthesis[7]
Ortaç 2019 (T-shunt ± tunneling)	25	Median duration 58 h	100% rapid resolution	84.2% ED; 15.8% unaided intercourse; 31.5% PDE5i; 47.4% severe ED[19]
Unal / Burnett 2024 (distal shunt ± Snake)	82 (26 Snake vs 56 no Snake)	Comparative Johns Hopkins cohort	92.3% vs 53.6% (p < 0.001)	Recurrence 4.2% vs 26.6% (p < 0.001); EF at follow-up 42.8% vs 50% (NS)[10]

Key Unal / Burnett 2024 takeaway: the Snake maneuver nearly doubled single-intervention resolution and reduced recurrence > 6-fold without worsening erectile function or adding complications.^[10]

Complications (Segal / Burnett series, n = 10):^[8]

• Wound infection with skin necrosis — 1/10
• Intraoperative urethral injury with subsequent urethrocutaneous fistula — 1/10
• Corporal perforation — theoretical (not reported in published series)
• Penile shortening / deformity — duration-driven, not procedure-driven

Salvage modification — Al-Ghorab + blunt cavernosotomy (Shiraishi–Matsuyama 2013). For very prolonged priapism (5–7 d) refractory to T-shunt/Snake, Pean forceps are used through the Al-Ghorab window to bluntly excise necrotic/fibrotic corporal tissue. Both reported patients achieved immediate resolution; one recovered partial sildenafil-responsive EF.^[20]

Practice pattern. In a multi-institutional survey, corporoglanular tunneling remained the favored first-line surgical intervention for prolonged ischemic priapism (71.2% of respondents); 89.9% had performed it (vs 62.8% who had performed penoscrotal decompression).^[14]

Pearls:

• Use blunt, controlled pressure; false passage or tunical perforation defeats the purpose.
• Tunnel only after a real distal exit has been made; forcing a dilator through a tiny puncture increases urethral- and tunical-injury risk.
• Persistent rigidity after tunneling should trigger reassessment for inadequate bilateral decompression, missed proximal clot, or nonviable corpora — and lower the threshold for PSD or early prosthesis.

---

Penoscrotal Decompression

Penoscrotal decompression (PSD) is a glans-sparing surgical strategy for prolonged / refractory ischemic priapism, first described by Fuchs, Shakir, McKibben et al. in 2018.^[11] Instead of communicating the corpus cavernosum with the corpus spongiosum through the glans, PSD makes direct corporotomies through a penoscrotal or proximal shaft incision, evacuating thrombosed blood from the mid-shaft and proximal corpora through a surgical field familiar to surgeons who perform penile-fracture repair or prosthesis implantation. Growing retrospective evidence suggests PSD may outperform corporoglanular tunneling in prolonged priapism while preserving the option of later prosthesis placement.^{[11][12][13][14]}

Rationale. PSD was developed to address three weaknesses of the distal-shunt + Snake paradigm:^[11]

• Distal shunts resolve only ~ 30% of priapism > 48 h, and corporoglanular tunneling may still leave heavily thrombosed mid-shaft / proximal corpora incompletely decompressed.
• Immediate malleable penile prosthesis (MPP) after failed distal shunts carries a high revision burden (37.5% in the Fuchs series, with 50% distal extrusion and 25% impending lateral extrusion).^[11]
• A penoscrotal / proximal-shaft approach gives direct access to the mid-shaft corpora through a familiar plane and spares the glans, preserving future prosthesis options.

Step-by-step:^[11][12][13]

1. Regional or general anaesthesia in an OR setting.
2. Penoscrotal incision (Fuchs original) at the penoscrotal junction, similar to implant exposure — or a proximal penile shaft incision (Basile 2025 modification) familiar from penile-fracture repair, which avoids the penoscrotal junction and may facilitate quicker bilateral exposure and later IPP placement.^[13]
3. Foley catheter; dissect through dartos to expose tunica albuginea of both corpora cavernosa; incise Buck's fascia.
4. Bilateral longitudinal (or transverse) corporotomies in the tunica albuginea.
5. Express dark, clotted blood; manual proximal and distal shaft compression assists evacuation; saline irrigation as needed.
6. Bilateral decompression is strongly preferred — unilateral PSD has measurable recurrence (20% in the Baumgarten series); bilateral PSD had zero recurrence.^[12]
7. Close tunical incisions primarily with absorbable suture (3-0 PDS or Vicryl).
8. Layered wound closure; compressive dressing.

Efficacy and outcomes:

Series	n	Duration	Key outcomes
Fuchs 2018 (PSD vs MPP after failed distal shunt)	6 PSD / 8 MPP	Median 61 h	PSD 6/6 resolution, 100% immediate pain relief, 0% revision; MPP 100% resolution but 37.5% revision (50% distal extrusion, 25% impending lateral extrusion)[11]
Baumgarten 2020 (multi-institutional)	25 (27 procedures)	Mean 71 h; 48% had failed prior corporoglanular shunting	Bilateral PSD 0% recurrence vs unilateral 20% (both salvaged with bilateral PSD); 60% spontaneous EF adequate for penetration; median IIEF-5 drop 3.5 points; 2/25 went on to uneventful IPP[12]
Basile 2025 (proximal-shaft PSD; longest follow-up)	26 (85% bilateral)	Median 47 h (IQR 36.5–58.8); half > 48 h	96% immediate detumescence, 92% complete pain relief, 69% overall success (73% for bilateral); 8% complications; satisfactory EF (± PP) in 86%; 2/13 IPP-infection explants; median FU 10.4 mo; earlier and bilateral PSD perform better[13]
VanDyke 2023/2024 surgeon survey	141 surgeons	Perception study	Among surgeons who had performed both, 47.3% rated PSD "Very/Extremely Effective" vs 18.7% for corporoglanular tunneling (p < 0.001); perceived meaningful sexual recovery similar (44.0% vs 44.6%); tunneling remained the more widely practiced technique (89.9% had performed it vs 62.8% for PSD)[14]

Comparison across surgical options:

Feature	Distal shunts	Snake (corporoglanular tunneling)	PSD	Immediate MPP after failed shunt
Approach	Through glans	Through glans	Penoscrotal / proximal shaft	Penoscrotal
Glans-sparing	No	No	Yes	Yes
Resolution (prolonged)	~ 30% (> 48 h)	53–92%	69–100%	100%
Recurrence (bilateral)	Variable	4.2%	0%	0%
Spontaneous EF	20–50%	42–50%	60%	N/A (prosthesis-dependent)
Revision rate	Variable	Low	0% (Fuchs)	37.5% (Fuchs)
Complication rate	0–42.5%	~ 10%	8%	0–13.6%
Preserves future prosthesis	Yes	Yes	Yes (uneventful IPP documented)	N/A

Complications. PSD has a notably low complication profile: 8% in the Basile series, no urethral injuries or wound infections specifically attributable to PSD in the published literature (in contrast to the Snake maneuver's 10% urethral injury / 10% wound-infection signal), and no glans necrosis risk by design. ED in 38–40% of patients is duration-driven rather than procedure-driven.^[12][13]

Prosthesis preservation. Because PSD avoids the glans entirely and closes the corporotomy primarily, future IPP placement remains feasible — Baumgarten documented two uneventful subsequent IPPs, and Basile reported 86% satisfactory EF (with or without PP) across the cohort, although 15% (2/13) of PP recipients required explantation for infection.^[12][13]

Place in the algorithm. Per current evidence and the EAU / AUA framework with the Schifano 2025 post-shunting narrative review:^[1][3][21]

1. Aspiration / irrigation → intracavernosal phenylephrine.
2. Distal shunt (T-shunt or Al-Ghorab) ± Snake.
3. PSD when distal shunting fails to fully detumesce — and increasingly considered as a primary alternative to corporoglanular tunneling in prolonged priapism.^[13][14]
4. Early penile prosthesis when smooth-muscle necrosis is confirmed or duration / clinical signs argue against any decompression attempt.

Limitations. All data are retrospective, with small cohorts (n = 6–26) and no RCTs. Efficacy is still time-dependent (best < 36 h), PSD requires an OR rather than a bedside setting, and only ~ 60% of fellowship-trained male-genital surgeons have personally performed the procedure.^[13][14]

---

Proximal and Venous Shunts

Proximal shunts were historically used after distal shunt failure. They are now largely de-emphasized or abandoned because distal shunts with tunneling, PSD, and early prosthesis have clearer roles and lower anatomic morbidity. The EAU 2024 systematic review explicitly recommends that proximal / venous shunts should be abandoned given their morbidity and ED profile relative to alternatives.^[1][2][5]

Quackels Shunt

First described by Quackels in 1964 as a proximal cavernospongiosal shunt: a direct side-to-side anastomosis between the corpus cavernosum and the adjacent corpus spongiosum at the proximal penile shaft or perineum, where the two structures lie in immediate anatomic apposition. The original rationale was that in prolonged priapism, the distal corpora may be so heavily thrombosed that distal shunts fail to drain the proximal corporal bodies — opening a window at the proximal level was meant to bypass the thrombosed distal tissue.^[5][22]

Step-by-step (Quackels):^[5]

1. General or regional anaesthesia (cannot be performed under local alone, unlike most distal shunts).
2. Lithotomy position for perineal and proximal-shaft access; Foley catheter to protect the urethra.
3. Perineal or penoscrotal-junction incision exposing the proximal corpora cavernosa and bulbar corpus spongiosum.
4. Dissect through Buck's fascia to expose the tunica albuginea of the corpus cavernosum and the adjacent corpus spongiosum.
5. Excise an elliptical or circular window from the apposed walls of corpus cavernosum and corpus spongiosum; suture the tunical edges together with absorbable suture to create a watertight side-to-side anastomosis.
6. Unilateral or bilateral; bilateral is more commonly performed for maximum drainage.
7. Express thrombosed blood through the new fistula into the spongiosum / systemic venous return.
8. Layered closure over a urethral catheter.

Quackels vs Grayhack — the two classic proximal shunts:

Feature	Quackels	Grayhack
Year	1964	1964
Drainage pathway	Corpus cavernosum → corpus spongiosum	Corpus cavernosum → saphenous vein
Anastomosis	Direct side-to-side corporospongiosal	Vascular graft (saphenous vein interposition)
Vein harvest	No	Yes (saphenous from thigh)
Technical complexity	Moderate	High (vein harvest + microvascular anastomosis)
Urethral-injury risk	Higher (direct manipulation of spongiosum / urethra)	Lower
Pulmonary-embolism risk	Lower	Higher (theoretical, from venous-graft thrombosis)
Pooled potency rate	11.1–77.2%	11.1–77.2% (proximal pooled)

Efficacy:

• Cosgrove / LaRocque 1974 (early review of 100 shunt cases) — overall potency 61% across shunt types; little difference between Grayhack and Quackels; unilateral saphenous-vein shunts performed slightly better than bilateral; outcomes similar whether performed early or late.^[23]
• Nixon 2003 (n = 28) — reoperation uncommon after Al-Ghorab or Quackels (vs 92% of reoperated patients having had Winter); however ~ 90% had ED at follow-up regardless of shunt type; only 10% preserved pre-morbid EF and 15% achieved partial unaided erection.^[3]
• Tabibi 2010 (small comparative, n = 16; ≥ 2-yr follow-up; 5 Winter / 7 Al-Ghorab / 4 Grayhack) — mean duration 51 h; Grayhack 2/4 impotent, 1 potent, 1 sildenafil-responsive; no surgical complications; sample too small for firm conclusions.^[24]
• Zheng 2013 (n = 9 prolonged priapism, mixed shunt types incl. 1 Grayhack) — 100% resolution but 66.7% postoperative ED; > 72 h cases had no response to PDE5i — authors recommended early prosthesis instead.^[25]
• EAU systematic review 2024 — proximal shunts (n = 209): resolution 5.7–100%, potency 11.1–77.2%; distal shunts (n = 274): resolution 18.7–100%, potency 20–100%; prostheses (n = 194): 100% resolution, satisfaction 60–100%. Panel concluded proximal / venous shunts should be abandoned.^[1]

Quackels-specific complications. Beyond the duration-driven ED that affects all priapism surgery, Quackels carries distinctive risks from corporospongiosal manipulation:^[26][27][28]

• Urethral injury — direct dissection of the spongiosum places the urethra at risk.
• Urethrocavernous fistula — Robbins 1984 reported a late-developing urethrocavernous fistula 3 months post-cavernospongiosum shunt.^[27]
• Combined urethrocutaneous + urethrocavernous fistula — Manjunath 2015 reported simultaneous urethrocutaneous and urethrocavernous fistulae after proximal corporospongiosal shunt requiring suprapubic urinary diversion.^[26]
• Persistent ("permanent open") shunt with venous leak — Kulmala 1995 studied 26 patients with post-shunt impotence and found a permanent open shunt on cavernosography in 5/26 (19.2%); all 5 were cured of impotence by shunt closure — suggesting a meaningful subset of post-Quackels ED is mechanically reversible if recognized.^[28]
• Wound infection, cavernositis, penile shortening from corporal fibrosis.

Current status. The Quackels shunt is largely obsolete in contemporary practice:

• Burnett / Brant–Lue T-shunt + Snake provides proximal corporal decompression through a distal approach, eliminating the original rationale for proximal shunting.^[6][9]
• Penoscrotal decompression achieves proximal-corporal drainage with lower morbidity and better EF preservation.^[11][13][21]
• Early malleable / inflatable penile prosthesis offers 100% resolution and 60–100% satisfaction in prolonged / refractory cases.^[1][17]
• The urethral-injury and persistent-shunt risk profile is not justified given safer alternatives.^[26][27][28]

Alnajjar & Muneer (2022) frame the consensus succinctly: "proximal shunts (Quackels or Grayhack) are no longer routinely performed."^[2] Quackels remains a procedure to recognize in historical literature and to consider only where modern techniques (Snake, PSD, prosthesis) are unavailable.

Grayhack Shunt

First described by Grayhack, McCullough, O'Conor, and Trippel in 1964 as a proximal cavernovenous shunt: a segment of great saphenous vein is mobilized, tunneled subcutaneously, and anastomosed end-to-side to the corpus cavernosum so that corporal blood drains into the systemic venous circulation rather than into an adjacent penile structure.^[5][29] Conceptually distinct from Quackels (which drains into the adjacent corpus spongiosum), the Grayhack offers a high-capacity venous conduit but at the cost of vein harvest, microvascular anastomosis, donor-site morbidity, and the unique risk of a persistently patent graft causing venous-leak ED.

Step-by-step (Grayhack):^[5][29]

1. General or regional anaesthesia; supine, ipsilateral leg prepped to access the saphenous vein.
2. Great saphenous vein identified at the groin / proximal medial thigh; a segment of adequate length harvested, ligated distally, flushed with heparinised saline.
3. Separate penoscrotal-junction or proximal-shaft incision to expose the tunica albuginea of the corpus cavernosum.
4. Small elliptical or circular corporotomy in the tunica.
5. Saphenous-vein graft tunneled subcutaneously from groin to penile incision and anastomosed end-to-side to the corpus cavernosum with interrupted 5-0 / 6-0 suture.
6. Unilateral preferred over bilateral — Cosgrove / LaRocque found unilateral saphenous-vein shunts performed better than bilateral.^[23]
7. Confirm free flow of dark deoxygenated blood from corpus → graft → systemic venous return.
8. Layered closure at both sites; compressive penile dressing; urethral catheter optional.

Efficacy:

Series	n	Setting	Resolution	Erectile function / note
Cosgrove / LaRocque 1974 (literature review)	100 cases (mixed shunts)	Early shunt literature	—	Overall potency 61%; little difference between Grayhack and Quackels; unilateral > bilateral saphenous-vein shunts; outcomes similar early vs late[23]
Resnick / Grayhack 1975 (pediatric)	2 boys (trauma; idiopathic)	Bilateral corporosaphenous	Both effectively treated	One of the earliest pediatric Grayhack reports[30]
Moloney 1975 (saphenocavernous bypass)	11 over 10 yr	Refractory ischemic priapism	Uniformly good if performed < 36 h; prior aspiration/irrigation extended that window	Persisting graft patency was associated with impotence — recommended graft ligation if no erection by 3 mo[31]
Richard 1979	12 (8 saphenocavernous)	French series	7/8 (87.5%) detumescence	5/8 (62.5%) potency preserved; earlier operation = lower secondary impotence[32]
Nixon 2003	28 (mixed)	Refractory low-flow	46% reoperation overall; uncommon after Al-Ghorab or Quackels (proximal venous shunts not separately stratified)	~ 90% ED regardless of shunt type[3]
Kulmala 1995	26 with post-shunt impotence	Cavernosographic survey	—	5/26 (19.2%) had a permanent open shunt; all 5 cured by shunt closure — directly relevant to Grayhack persistent-graft physiology[28]
Zheng 2013	9 (1 Grayhack after failed Winter)	Prolonged ischemic priapism	100% (mixed)	66.7% ED; > 72 h cases unresponsive to PDE5i[25]
EAU systematic review 2024	Proximal pooled n = 209	Mixed Grayhack + Quackels	5.7–100%	Potency 11.1–77.2%; panel: abandon proximal / venous shunts[1]

Grayhack vs Quackels — head to head:

Feature	Grayhack	Quackels
Year	1964	1964
Drainage	Corpus cavernosum → saphenous vein (systemic venous)	Corpus cavernosum → corpus spongiosum
Vein harvest	Yes (saphenous)	No
Surgical complexity	High (vein harvest + vascular anastomosis)	Moderate
Urethral-injury risk	Lower (no urethral manipulation)	Higher (direct spongiosum dissection)
Persistent-shunt / venous-leak risk	Higher (vein graft may stay patent)	Present but lower
Pulmonary-embolism risk	Higher (theoretical, via systemic venous return)	Lower
Unilateral vs bilateral	Unilateral preferred (Cosgrove)	Bilateral often performed

Grayhack-specific complications.^{[1][10][28][31]}

• Persistent ("permanent open") graft with venous-leak ED — the defining Grayhack-physiology risk. Kulmala documented this in 19.2% of post-shunt-impotence patients; Moloney specifically recommended shunt ligation if erection has not returned at 3 months.
• Graft thrombosis — the saphenous graft may occlude, leaving the shunt non-functional.
• Pulmonary embolism — theoretical concern from mobilization of thrombosed corporal blood into systemic venous return or graft-thrombus embolisation.
• Donor-site morbidity — wound infection, hematoma, seroma, lymphocele at the groin; loss of the saphenous segment for future CABG or vascular reconstruction.
• Duration-driven ED, penile shortening / fibrosis, multi-site wound infection.

Modern cavernovenous variants (kept brief; see Barry section below for caverno-dorsal-vein detail):

• Barry shunt (1976) — corpus cavernosum to dorsal penile vein; smaller surgical field, no saphenous mobilization, cannot cause urethrocutaneous fistula; can convert to Grayhack/Quackels without repositioning if unsuccessful.^[33]
• Chiou 2009 cavernosal-dorsal-vein shunt — saphenous-vein graft connecting corpus cavernosum to the deep dorsal vein. In 16 patients (10 with prior failed shunts), 100% resolution; 69% had erections at follow-up (6 with intercourse); Doppler confirmed graft patency and restored cavernosal arterial flow in 12/13 studied.^[34]
• Kilinc 2009 temporary cavernosal-cephalic vein shunt — minimally invasive angiocath / serum-set construct to the cephalic vein; 13/15 (86.7%) detumescence; the 2 failures required formal saphenocavernous shunting; 3/13 ED at 12 mo.^[35]

Current status. The Grayhack is largely obsolete:

• EAU 2024 explicitly recommends abandoning proximal / venous shunts.^[1]
• T-shunt or Al-Ghorab + Snake achieves proximal corporal decompression through a distal approach, removing the original rationale.^[6][9]
• Penoscrotal decompression drains the proximal corpora with lower morbidity and better EF preservation.^[11][13]
• Early penile prosthesis offers 100% resolution and 60–100% satisfaction in prolonged / refractory cases.^[1][17]
• The Grayhack-specific risks (graft thrombosis, persistent open shunt, donor-site morbidity, surgical complexity) are not justified by alternatives.

The Grayhack and its variants persist mainly in historical literature and as the conceptual ancestor of the Barry / caverno-dorsal-vein shunt — which the recent Soydaş 2025 algorithm and Micoogullari 2021 series have proposed as a possible niche option, with the shunt electively closed at 2 months to mitigate the persistent-open-shunt problem inherent to all cavernovenous strategies.^[15][16]

Barry / Caverno-Dorsal Vein Shunt

First described by John M. Barry in 1976 as a simpler, smaller-field cavernovenous alternative to the Grayhack — using the dorsal vein of the penis (deep or superficial) as the drainage target rather than the saphenous vein.^[33] The technique sits within the same cavernovenous family as Grayhack but eliminates the donor-site morbidity, large surgical field, and urethrocutaneous-fistula risk of the Grayhack and Quackels procedures respectively. Recent series — particularly the Micoogullari 2021 planned-closure construct and the Chiou 2009 saphenous-graft modification — have driven a measured resurgence of interest, with some authors advocating Barry shunting as a first-line surgical option for refractory ischemic priapism.^[15][16][34]

Relevant venous anatomy. The penis drains via three distinct systems:

• Superficial dorsal vein — subcutaneous; drains skin and prepuce into external pudendal → femoral / saphenous.
• Deep dorsal vein (DDV) — in the midline dorsal groove between the corpora cavernosa, deep to Buck's fascia; drains glans and all three corpora via emissary and circumflex veins into Santorini's preprostatic plexus. Principal drainage of the flaccid corpus cavernosum and the target of the standard Barry shunt.
• Cavernosal (crural) veins — emerge from each crus and drain only the corpora into the internal pudendal vein.

In ischemic priapism the veno-occlusive compression of emissary veins is pathologically sustained; the Barry shunt bypasses that obstruction by creating a direct corpus-cavernosum → dorsal-vein communication and restoring venous outflow.

Step-by-step (original Barry, 1976):^[33]

1. General or regional anaesthesia; supine.
2. Dorsal mid-shaft penile incision — single small field; no patient repositioning required.
3. Identify and mobilize the deep dorsal vein (between Buck's fascia and tunica) and/or the superficial dorsal vein.
4. Small corporotomy in the tunica adjacent to the mobilized vein.
5. Ligate the chosen dorsal vein distally; anastomose the proximal end end-to-side to the corpus cavernosum with fine suture.
6. Confirm free flow of dark deoxygenated blood from corpus → dorsal vein → systemic return; detumescence.
7. Layered closure; compressive dressing.

If the Barry shunt is unsuccessful, a Grayhack or Quackels can be performed without repositioning — a deliberate practical advantage of Barry's original design.^[33]

Modifications:

• Micoogullari 2021 — planned closure at 2 months.^[15] Protocol: emergency aspiration + corporal blood gas → 0.01% adrenaline irrigation × 5 at 20-min intervals → Barry shunt if priapism persists → elective shunt closure at 2 months. This directly addresses the Grayhack-era "permanent open shunt" problem (Kulmala / Moloney) that drove EAU 2024 to recommend abandonment of cavernovenous shunts more broadly.^[1][28][31]
• Chiou 2009 — DDV + saphenous-vein-graft interposition.^[34] Hybrid construct using the dorsal vein as drainage target (Barry) but a saphenous-vein graft as the conduit (Grayhack) — larger-caliber lumen at the cost of reintroducing vein harvest.
• Kilinc 2009 — temporary external cavernosal-cephalic shunt.^[35] Angiocaths + serum sets bridging the corpora to a forearm cephalic-vein angiocath; bedside, no OR required.
• Soydaş 2025 algorithm — proposes incorporating caverno-dorsal-vein shunting into a prolonged-priapism algorithm.^[16]

Efficacy:

Series	n	Setting	Resolution	EF / note
Barry 1976 (original)	2	6-day (DDV) and 3.5-day (superficial DV) priapism	2/2 resolved	"Anatomically sound, small surgical field, no saphenous mobilization, cannot cause urethrocutaneous fistula"[33]
Chiou 2009 (DDV + SVG)	16 (age 15–65; duration 32 h–8 d; 10/16 had prior failed shunting)	Refractory / salvage	100% (16/16)	69% (9/13) had erections at ≤ 6.5 yr; 6 with intercourse; Doppler-confirmed graft patency in 100% and restored cavernosal arterial flow in 12/13 (92%)[34]
Micoogullari 2021 (Barry + planned closure)	10	Median duration 13.5 h (range 7–38)	100% (10/10)	80% (8/10) maintained EF; 2/10 → IPP; shunt electively closed at 2 mo[15]
Kilinc 2009 (temporary cephalic-vein)	15	Bedside angiocath construct	13/15 (86.7%)	2 failures → saphenocavernous shunt; 3/13 ED at 12 mo[35]

Barry vs Grayhack — what Barry was designed to fix:

Feature	Barry	Grayhack
Drainage target	Dorsal penile vein	Saphenous vein
Vein harvest	No (original) / yes (Chiou modification)	Yes (always)
Surgical field	Small (dorsal penis only)	Large (groin + penis)
Donor-site morbidity	None (original)	Present (thigh wound)
Urethrocutaneous-fistula risk	None	None
Surgical complexity	Low–moderate	High
Patient repositioning	Not required	May be required
Escalation if it fails	Can proceed to Grayhack/Quackels without repositioning	—

Complications. The defining cavernovenous-shunt risk — persistent ("permanent open") shunt with venous-leak ED — applies to Barry as much as to Grayhack. Kulmala documented this in 19.2% of post-shunt-impotence patients with 100% impotence reversal on closure, and Moloney recommended graft ligation if erection had not returned by 3 months.^[28][31] The Micoogullari 2021 protocol's planned 2-month closure is the direct procedural answer to this physiology, and likely contributes to the 80% EF preservation they report — substantially above the 11.1–77.2% pooled potency band for proximal shunts in the EAU 2024 dataset.^[1][15] Barry-specific reports document no urethrocutaneous fistulae, no saphenous donor-site morbidity (original technique), and no recurrence in the Micoogullari and Chiou series.^[15][33][34]

Current status and algorithmic placement. EAU 2024 broadly recommends abandoning proximal / venous shunts — but that recommendation rests primarily on Grayhack and Quackels data, not Barry-specific outcomes.^[1] The Barry-shunt series (Chiou 100% / 69%; Micoogullari 100% / 80%) exceed pooled proximal-shunt data and rival or exceed many distal-shunt series, and Micoogullari explicitly positions the Barry shunt as a candidate first-line surgical treatment for refractory low-flow priapism. The procedure has nevertheless not been incorporated into AUA/SMSNA 2022 or EAU recommendations, given the very small total evidence base.^[1][15][34]

The clearest pragmatic niches:

• After failed distal shunting — Chiou's 10/16 prior-failed-shunt cohort with 100% resolution argues for Barry-style cavernosal-dorsal-vein shunting as a salvage option.^[34]
• When saphenous harvest is undesirable — original Barry preserves the saphenous segment.^[33]
• When planned closure is feasible — Micoogullari's 2-month elective ligation is the construct most likely to preserve EF.^[15]
• As a stepping stone — failure converts to Grayhack/Quackels without repositioning.^[33]

All-shunt summary

Shunt	Year	Type	Approach	Resolution	Potency	Current status
Winter	1976	Distal	Percutaneous needle	18.7–100%	20–100%	Used but highest failure rate
Ebbehoj	1974	Distal	Percutaneous blade	18.7–100%	20–100%	Used; intermediate failure
T-Shunt (Lue)	2009	Distal	Percutaneous (90° rotation)	18.7–100%	20–100%	Widely used; Snake-compatible
Al-Ghorab	1973	Distal	Open excision	18.7–100%	20–100%	Most reliable distal; Snake-compatible
Quackels	1964	Proximal	Open corporospongiosal	5.7–100%	11.1–77.2%	Largely abandoned
Grayhack	1964	Proximal	Open with saphenous-vein graft	5.7–100%	11.1–77.2%	Largely abandoned
Barry	1976	Venous	Open to dorsal penile vein	100% (small series)	~ 80%	Niche / planned-closure construct
Chiou cavernosal-dorsal-vein	2009	Venous	Saphenous-graft to deep dorsal vein	100% (n = 16, 10 prior failed)	69%	Salvage option after failed shunting

---

Early Malleable Penile Prosthesis for Refractory Ischemic Priapism

Early malleable penile prosthesis (MPP) is the preferred definitive surgical management for refractory ischemic priapism (RIP) — priapism persisting beyond 36–48 hours despite conventional interventions. Ralph's landmark UCLH series achieved 100% priapism resolution, 96% satisfaction, and 0% penile shortening, simultaneously treating the priapism and the inevitable ED that follows prolonged corporal ischemia.^{[2][17][36][37]}

Pathophysiological rationale. Corporal smooth-muscle damage is time-dependent and ultimately irreversible: by > 48 h the corpus cavernosum is essentially necrotic and EF recovery is no longer realistic even if detumescence is achieved by shunting.^[5][17][36] Implantation in the acute soft-corpora window, before fibrotic remodeling consolidates, accomplishes four things at once:

1. Mechanical detumescence — the prosthesis displaces the trapped blood.
2. Length preservation — the cylinder functions as an internal stent / tissue expander during fibrotic remodeling.
3. Proactive ED treatment — addresses the inevitable post-priapism EF loss rather than reacting to it.
4. Avoidance of the dense-fibrosis surgery — Zacharakis showed 80% of delayed implants require a second corporotomy and downsized cylinders due to fibrosis.^[38]

Imaging-guided patient selection — contrast-enhanced penile MRI. T2-weighted gadolinium-enhanced penile MRI differentiates viable from nonviable corporal smooth muscle. Ralph 2010 reported 100% sensitivity of MRI for predicting nonviable smooth muscle against corporal-biopsy reference; an additional 10 MRI-nonviable patients without biopsy all developed ED, and 5 MRI-viable patients all maintained EF.^[39] Absent corporal contrast enhancement supports moving directly to prosthesis rather than further shunting attempts.^[39][47] The ISSM survey found < 40% of respondents currently use MRI or corporal biopsy in this setting — a practice gap.^[40]

Guideline positioning.

• EAU 2024 — best outcomes in ischemic priapism > 48 h are seen with penile prosthesis implantation; proximal/venous shunts should be abandoned.^[1]
• AUA/SMSNA 2022 — prosthesis is indicated when shunting or PSD fails, or for priapism > 36 h.^[3]
• Pang 2025 / Calopedos 2025 — early prosthesis is the preferred management strategy for RIP.^[2][36]

Why malleable over inflatable in the acute setting:^[17][36][37]

Feature	Malleable (semi-rigid)	Inflatable (3-piece IPP)
Preferred for acute / early implantation	Yes	Generally avoided acutely
Surgical complexity	Lower	Higher (reservoir + pump)
Operative time	Shorter	Longer
Infection risk	Lower (fewer components)	Higher
Corporal dilation	Minimal — soft necrotic tissue	Same, but precise sizing critical
Acts as internal stent / tissue expander	Yes	Yes (more complex)
Concealment	Poor	Better
Elective exchange to IPP later	Yes (~ 6–12 mo)	N/A
Cost	Lower	Higher

Step-by-step (early MPP for refractory ischemic priapism):^[37][41][42]

1. Confirm ischemic priapism with corporal blood-gas (dark blood, pO₂ < 30 mmHg, pH < 7.25); consider MRI to confirm nonviable corpora.^[39]
2. Counsel about permanent loss of native erections in exchange for guaranteed detumescence, length preservation, and restored ability to have intercourse.
3. Broad-spectrum antibiotic prophylaxis; consider antibiotic-coated devices (InhibiZone / Titan hydrophilic).
4. Penoscrotal or subcoronal incision.
5. Bilateral corporotomies — the necrotic corpora are notably soft and dilate with minimal force; full Hegar progression is rarely needed.
6. Evacuate residual thrombosed blood; irrigate.
7. Measure full corporal length distally and proximally — full-length cylinders maximize length preservation.
8. Insert malleable rods bilaterally — proximal tip seated in crura, distal tip beneath the glans.
9. Salem sling-suture distal-erosion prophylaxis (especially after prior distal shunting that has weakened the tunica): nonabsorbable suture taken through the cylinder and the edges of the opened tunica fixes the cylinder to the corporotomy edges. In Salem's 12-patient series (11 with prior failed shunts) this construct yielded 0% distal erosion at median 15-mo follow-up.^[42]
10. Close corporotomies with 2-0 / 3-0 absorbable.
11. Layered wound closure; compressive dressing.
12. Discharge within 24 h is typical.^[41]

Key clinical evidence:

Series	n	Setting	Outcome
Ralph 2009 UCLH (landmark)	50 (13 prior failed shunts)	Acute ischemic priapism; 86% malleable, 14% IPP	100% resolution; 84% successful intercourse; 96% overall satisfaction; 0% penile shortening; 6% infection; 12% revision; 12% later elective MPP→IPP exchange[37]
Zacharakis 2014 UCLH (early vs delayed)	95 (68 early at median 7 d vs 27 delayed at median 5 mo)	Refractory ischemic priapism	Satisfaction 96% early vs 60% delayed; 80% of delayed required second corporotomy + downsized cylinders due to dense fibrosis; significant shortening was the main driver of delayed-group dissatisfaction[38]
Barham 2023 multicenter (IPP)	62 priapism + 62 controls (no priapism)	Early (≤ 6 mo) vs delayed (> 6 mo) IPP	Complication rate 0% early vs 40.5% delayed; all cylinder complications in delayed group occurred with full-sized cylinders — argues for early referral to prosthetic experts[43]
Tausch 2015 cost-effectiveness	14	RIP at urban safety-net hospital	Mean preop 82 h of RIP, 4 ER visits, 2 admissions, 1.5 shunts, 5 irrigation/drainage, 5 hospital days, estimated preop cost US $83,818; all discharged ≤ 24 h after MPP[41]
Salem 2010 distal-erosion prevention	12 (11 prior failed shunts)	Mean duration 120 h	100% successful insertion; 0% distal erosion and 0% infection with sling-suture construct; 100% intercourse and satisfaction at median 15 mo[42]
Dighero 2025 long-term QoL (QoLSPP)	39 of 167 post-priapism implants	Median 9 yr post-priapism	Satisfactory scores on 7/16 QoLSPP items; 100% would not regret the prosthesis; 100% satisfied to live the rest of life with device in situ; no significant difference malleable vs inflatable[44]
Butaney 2019 ISSM survey	251 ISSM members	Practice patterns	70.9% more comfortable with MPP than shunt, yet ~ 80% still favor shunts first-line; experience higher with prostheses than shunts — points to underutilization gap[40]

Malleable → inflatable exchange. A central advantage of acute MPP is the option for elective exchange to a 3-piece IPP at 6–12 months once corporal remodeling has stabilized — Ralph reported a 14% exchange rate, and the corporal space maintained by the malleable rod makes the later IPP insertion considerably easier than a primary delayed IPP into densely fibrotic tissue.^[37][38]

Complications. Early MPP has a favorable complication profile relative to both shunt surgery and delayed implantation:^{[1][17][37][38][42][43][46]}

• Infection — 0–6% (Ralph 6%, Salem 0%); managed by explantation + delayed reinsertion. Antibiotic-coated cylinders reduce this risk.
• Distal cylinder erosion / protrusion — particular risk when prior shunting has weakened the distal tunica; Salem sling suture eliminates this.^[42]
• Intraoperative corporal perforation — rare; described in 1/12 (SCD patient) in Salem; managed intraoperatively.^[42]
• Curvature — from asymmetric fibrosis or malposition; a contributor to revision in Ralph.^[37]
• Mechanical failure — relevant to IPPs only; malleable rods have no mechanical components.
• Penile shortening — 0% in early implantation vs. main driver of delayed-implantation dissatisfaction (Zacharakis).^[37][38]

Three-piece IPP in the acute setting. Although MPP is preferred, some centers acutely place an IPP. Clavijo 2017 detailed techniques for IPP placement into fibrotic corpora including cutting cavernotomes and narrow-base cylinders (Coloplast Titan narrow-base).^[45] Barham's multicenter data argue that even when an IPP is the planned definitive device, placing it early (≤ 6 mo) rather than delayed (> 6 mo) reduces complications from 40.5% to 0%.^[43]

Special populations.

• Sickle cell disease (29% of the Tausch cohort) — higher risk of corporal perforation; perioperative hydration / transfusion per hematology; recurrent priapism makes definitive prosthesis particularly valuable.^[41][42]
• Prior failed shunt surgery — weakened distal tunica; use the Salem sling suture.^[42]

Algorithmic placement and biases. Per current evidence:^{[2][3][21][36]}

1. Aspiration / irrigation → intracavernosal phenylephrine.
2. Distal shunt (T-shunt or Al-Ghorab) ± Snake — for shorter-duration disease with likely-viable corpora.
3. PSD when distal shunting fails to fully detumesce.
4. Early MPP when priapism is > 36–48 h despite the above, when shunting / PSD have failed, when MRI/biopsy shows necrotic corpora, or when the patient prefers definitive treatment with guaranteed length preservation.

Situation	Bias
Shorter duration, viable corpora, patient strongly wants native EF chance	Distal shunt with tunneling or PSD
Failed shunt / failed PSD	Acute malleable prosthesis
Duration > 36–48 h, MRI / biopsy with necrotic corpora	Early MPP (length-preserving)
Borderline duration (36–48 h) with patient strongly desiring native-EF chance	Shared decision-making; MRI may tip the call
Patient medically unstable or infected field	Temporize safely; defer implant if risk outweighs length preservation
Prior shunting with weakened distal tunica	MPP with Salem sling-suture distal fixation

Penile prosthesis vs shunt — head to head:^{[1][37][38][41]}

Parameter	Early prosthesis	Distal shunts	Proximal shunts
Resolution	100%	18.7–100%	5.7–100%
Potency / functional intercourse	26.3–100% (96% in Ralph)	20–100%	11.1–77.2%
Satisfaction	60–100% (96% Ralph)	Not systematically reported	Not systematically reported
Complications	0–13.6%	0–42.5%	0–42.5%
Length preservation	Yes	Variable	Variable
Treats ED proactively	Yes	No	No
Cost-effective	Yes (avoids repeated interventions)	No (often escalates)	No

Limitations. The choice is irreversible — native erectile function is permanently lost — which is a meaningful concern in borderline 36–48 h windows where some residual EF recovery might still occur. The evidence base is retrospective with no RCTs; availability of prosthetic surgical expertise on emergency call is not universal; and patient counseling in acute distress is challenging.^[17][36][40]

---

Procedure Summary Table

Procedure	Category	Approach	Best for / indication	Key risk
Winter Shunt	Distal corporoglanular	Percutaneous Tru-Cut needle through glans	Simplest distal shunt for early refractory ischemic priapism	Small shunt closes; poor clot evacuation in prolonged priapism; highest failure rate among distal shunts
Ebbehoj Shunt	Distal corporoglanular	No. 11 blade stab through glans	Simple percutaneous blade shunt with larger opening than Winter	Urethral injury if directed too ventrally; still small; not Snake-compatible
T-Shunt (Lue)	Distal corporoglanular	No. 10 blade rotated 90° to create T-shaped distal tunical opening	Preferred percutaneous distal shunt when robust drainage and tunneling access are needed	Glans-based injury; urethral injury if trajectory wrong; urethrocutaneous fistula with Snake
Al-Ghorab Shunt	Distal corporoglanular	Open glans incision with distal tunical window	Large open distal shunt for failed percutaneous shunt or prolonged clot burden	Glans injury, urethral injury, cavernosospongiosal fistula
Burnett Snake Maneuver	Tunneling adjunct	7–8 mm Hegar dilator passed proximally through distal shunt window (T-shunt or Al-Ghorab)	Disrupts full-length corporal clot after T-shunt or Al-Ghorab; 92.3% vs 53.6% resolution (Unal/Burnett 2024)	False passage or corporal perforation if forced
Penoscrotal Decompression	Glans-sparing decompression	Penoscrotal or proximal shaft corporotomies	Direct proximal evacuation / irrigation for prolonged priapism or failed distal shunt	Requires open exposure; erectile recovery duration-dependent
Quackels Shunt	Proximal / historical	Perineal cavernospongiosal shunt	Historical salvage after distal failure	Urethral injury, fistula, cavernositis, ED
Grayhack Shunt	Proximal / historical	Saphenous vein to corpus cavernosum	Historical caverno-venous drainage	Technical burden, pulmonary embolism concern, ED
Barry / Caverno-Dorsal Vein	Proximal / niche	Corpus cavernosum to dorsal penile vein	Small-series / niche venous-drainage option	Limited data; not mainstream algorithm
Early Malleable Penile Prosthesis	Definitive salvage	Acute corporal dilation and malleable cylinder placement	Length-preserving definitive option for nonviable corpora, failed shunts, or very late priapism	Implant infection / erosion in inflamed ischemic tissue

---

References

1. Milenkovic U, Cocci A, Veeratterapillay R, et al. Surgical and minimally invasive treatment of ischaemic and non-ischaemic priapism: a systematic review by the EAU Sexual and Reproductive Health Guidelines Panel. Int J Impot Res. 2024;36(1):36-49. doi:10.1038/s41443-022-00604-1

2. Pang KH, Alnajjar HM, Lal A, Muneer A. An update on mechanisms and treatment options for priapism. Nat Rev Urol. 2025. doi:10.1038/s41585-025-01069-9

3. Bivalacqua TJ, Allen BK, Brock G, et al. Acute ischemic priapism: an AUA/SMSNA guideline. J Urol. 2021;206(5):1114-1121. doi:10.1097/JU.0000000000002236

4. El-Achkar A, Arbuiso A, Marquardt Filho N, et al. Non-surgical vs surgical management for major ischemic priapism of 36 hours duration. J Sex Med. 2026;23(1):qdaf362. doi:10.1093/jsxmed/qdaf362

5. Johnson MJ, Kristinsson S, Ralph O, Chiriaco G, Ralph D. The surgical management of ischaemic priapism. Int J Impot Res. 2020;32(1):81-88. doi:10.1038/s41443-019-0197-9

6. Brant WO, Garcia MM, Bella AJ, Chi T, Lue TF. T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol. 2009;181(4):1699-1705. doi:10.1016/j.juro.2008.12.021

7. Zacharakis E, Raheem AA, Freeman A, et al. The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism. J Urol. 2014;191(1):164-168. doi:10.1016/j.juro.2013.07.034

8. Segal RL, Readal N, Pierorazio PM, Burnett AL, Bivalacqua TJ. Corporal Burnett "snake" surgical maneuver for the treatment of ischemic priapism: long-term followup. J Urol. 2013;189(3):1025-1029. doi:10.1016/j.juro.2012.08.245

9. Burnett AL, Pierorazio PM. Corporal "snake" maneuver: corporoglanular shunt surgical modification for ischemic priapism. J Sex Med. 2009;6(4):1171-1176. doi:10.1111/j.1743-6109.2008.01176.x

10. Unal S, Karakus S, Du Comb W, Burnett AL. Clinical outcomes of the Burnett "snake" maneuver shunt modification for ischemic priapism. J Sex Med. 2024;21(8):723-728. doi:10.1093/jsxmed/qdae078

11. Fuchs JS, Shakir N, McKibben MJ, et al. Penoscrotal decompression-promising new treatment paradigm for refractory ischemic priapism. J Sex Med. 2018;15(5):797-802. doi:10.1016/j.jsxm.2018.02.010

12. Baumgarten AS, VanDyke ME, Yi YA, et al. Favourable multi-institutional experience with penoscrotal decompression for prolonged ischaemic priapism. BJU Int. 2020;126(4):441-446. doi:10.1111/bju.15127

13. Basile G, Ralph D, Wardak S, Sangster P, Christopher N, Lee WG. Penoscrotal decompression should be considered for prolonged ischaemic priapism. J Sex Med. 2025;22(11):2072-2078. doi:10.1093/jsxmed/qdaf229

14. VanDyke ME, Smith WJ, Holland LC, et al. Current opinions on the management of prolonged ischemic priapism: does penoscrotal decompression outperform corporoglanular tunneling? Int J Impot Res. 2024;36(1):62-67. doi:10.1038/s41443-023-00808-z

15. Micoogullari U, Unal S, Alijla A, et al. Effectiveness of the caverno-dorsal vein shunt (Barry shunt) on prolonged ischaemic priapism and its effect on the post-operative long-term erectile function. Andrologia. 2021;53(2):e13945. doi:10.1111/and.13945

16. Soydaş T, Tunç OE, Uzundal H, et al. Barry shunt in prolonged ischemic priapism: a novel treatment algorithm. J Sex Med. 2025;22(11):2070-2071. doi:10.1093/jsxmed/qdaf240

17. Yassin M, Chen R, Ager M, Desouky E, Minhas S. Penile implants in low flow priapism. Int J Impot Res. 2023;35(7):651-663. doi:10.1038/s41443-023-00787-1

18. Mireku-Boateng AO. Surgical closure of persistent spongiosum-cavernosum fistula after Winter's procedure for priapism. Urol Int. 2001;66(4):216-217. doi:10.1159/000056618

19. Ortaç M, Çevik G, Akdere H, Ermeç B, Kadıoğlu A. Anatomic and functional outcome following distal shunt and tunneling for treatment ischemic priapism: a single-center experience. J Sex Med. 2019;16(8):1290-1296. doi:10.1016/j.jsxm.2019.05.015

20. Shiraishi K, Matsuyama H. Salvage management of prolonged ischemic priapism: Al-Ghorab shunt plus cavernous tunneling with blunt cavernosotomy. J Sex Med. 2013;10(2):599-602. doi:10.1111/j.1743-6109.2012.02973.x

21. Schifano N, Capogrosso P, Baldini S, et al. Current evidence on the management of ischaemic priapism post-shunting: a narrative review. Int J Impot Res. 2025. doi:10.1038/s41443-025-01078-7

22. Quackels R. Cure of a patient suffering from priapism by cavernospongious anastomosis. Acta Urol Belg. 1964;32:5-13.

23. Cosgrove MD, LaRocque MA. Shunt surgery for priapism: review of results. Urology. 1974;4(1):1-4. doi:10.1016/0090-4295(74)90098-3

24. Tabibi A, Abdi H, Mahmoudnejad N. Erectile function and dysfunction following low flow priapism: a comparison of distal and proximal shunts. Urol J. 2010;7(3):174-177.

25. Zheng DC, Yao HJ, Zhang K, et al. Unsatisfactory outcomes of prolonged ischemic priapism without early surgical shunts: our clinical experience and a review of the literature. Asian J Androl. 2013;15(1):75-78. doi:10.1038/aja.2012.63

26. Manjunath AS, Mazur DJ, Han JS, Gonzalez CM. Simultaneous urethrocutaneous and urethrocavernous fistula after proximal corporospongiosal shunt for priapism. Urology. 2015;85(3):e13-e14. doi:10.1016/j.urology.2014.12.018

27. Robbins DM, Crawford ED, Lackner HL. Late development of a urethrocavernous fistula after cavernospongiosum shunt for priapism. J Urol. 1984;132(1):126-127. doi:10.1016/s0022-5347(17)49496-1

28. Kulmala RV, Lehtonen TA, Lindholm TS, Tammela TL. Permanent open shunt as a reason for impotence or reduced potency after surgical treatment of priapism in 26 patients. Int J Impot Res. 1995;7(3):175-180.

29. Grayhack JT, McCullough W, O'Conor VJ Jr, Trippel O. Venous bypass to control priapism. Invest Urol. 1964;1:509-513.

30. Resnick MI, Holland JM, King LR, Grayhack JT. Priapism in boys. Management with cavernosaphenous shunt. Urology. 1975;5(4):492-495. doi:10.1016/0090-4295(75)90073-4

31. Moloney PJ, Elliott GB, Johnson HW. Experiences with priapism. J Urol. 1975;114(1):72-76. doi:10.1016/s0022-5347(17)66946-5

32. Richard F, Fourcade R, Le Guillou M, Jardin A, Kuss R. Etiological aspects and interest of early surgical management of priapism. Eur Urol. 1979;5(3):179-181. doi:10.1159/000473100

33. Barry JM. Priapism: treatment with corpus cavernosum to dorsal vein of penis shunts. J Urol. 1976;116(6):754-756. doi:10.1016/s0022-5347(17)58998-3

34. Chiou RK, Aggarwal H, Mues AC, Chiou CR, Broughton FL. Clinical experience and sexual function outcome of patients with priapism treated with penile cavernosal-dorsal vein shunt using saphenous vein graft. Urology. 2009;73(3):556-561. doi:10.1016/j.urology.2008.10.025

35. Kilinc M. Temporary cavernosal-cephalic vein shunt in low-flow priapism treatment. Eur Urol. 2009;56(3):559-562. doi:10.1016/j.eururo.2008.10.009

36. Calopedos R, Trubbia D, Ralph D, Lee WG. Early penile prosthesis implantation in refractory ischaemic priapism: a narrative review. Int J Impot Res. 2025. doi:10.1038/s41443-025-01199-z

37. Ralph DJ, Garaffa G, Muneer A, et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur Urol. 2009;56(6):1033-1038. doi:10.1016/j.eururo.2008.09.044

38. Zacharakis E, Garaffa G, Raheem AA, et al. Penile prosthesis insertion in patients with refractory ischaemic priapism: early vs delayed implantation. BJU Int. 2014;114(4):576-581. doi:10.1111/bju.12686

39. Ralph DJ, Borley NC, Allen C, et al. The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism. BJU Int. 2010;106(11):1714-1718. doi:10.1111/j.1464-410X.2010.09368.x

40. Butaney M, Thirumavalavan N, Rodriguez D, Gross MS, Munarriz R. Current practice in the management of ischemic priapism: an anonymous survey of ISSM members. Int J Impot Res. 2019;31(6):404-409. doi:10.1038/s41443-019-0120-4

41. Tausch TJ, Zhao LC, Morey AF, et al. Malleable penile prosthesis is a cost-effective treatment for refractory ischemic priapism. J Sex Med. 2015;12(3):824-826. doi:10.1111/jsm.12803

42. Salem EA, El Aasser O. Management of ischemic priapism by penile prosthesis insertion: prevention of distal erosion. J Urol. 2010;183(6):2300-2303. doi:10.1016/j.juro.2010.02.014

43. Barham DW, Chang C, Hammad M, et al. Delayed placement of an inflatable penile prosthesis is associated with a high complication rate in men with a history of ischemic priapism. J Sex Med. 2023;20(7):1052-1056. doi:10.1093/jsxmed/qdad075

44. Dighero I, Naylor K, Looney A, et al. Quality of life outcomes following penile prosthesis insertion in the post-ischaemic priapism setting. Int J Impot Res. 2025. doi:10.1038/s41443-025-01073-y

45. Clavijo RI, Sávio LF, Prakash NS, et al. Three-piece penile prosthesis implantation in refractory ischemic priapism — tips and tricks. Urology. 2017;106:233-235. doi:10.1016/j.urology.2017.04.032

46. Cocci A, Capogrosso P, Minhas S, et al. Penile prosthesis implantation: a systematic review of intraoperative and postoperative complications. Int J Impot Res. 2025. doi:10.1038/s41443-025-01108-4

47. von Stempel C, Walkden M, Kirkham A. Review of the role of imaging in the diagnosis of priapism. Int J Impot Res. 2024. doi:10.1038/s41443-024-00928-0